This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosen, T. Articles by Guller, S. Search for Related Content PubMed PubMed Citation Articles by Rosen, T. Articles by Guller, S.

Chronic Antagonism of Nuclear Factor-B Activity in Cytotrophoblasts by Dexamethasone: A Potential Mechanism for Antiinflammatory Action of Glucocorticoids in Human Placenta¹

Departments of Obstetrics and Gynecology (T.R., G.K., Y.M., E.-Y.W., C.J.L., S.G.) and Biochemistry (S.G.), New York University Medical Center, New York, New York 10016

Address all correspondence and requests for reprints to: Dr. Seth Guller, Department of Obstetrics and Gynecology, New York University Medical Center, Tisch Hospital, Room 531, 550 First Avenue, New York, New York 10016. E-mail: seth.guller{at}mcobg.med.nyu.edu

Circulating glucocorticoids are present in increasing quantities as human gestation progresses, peaking during labor whether it occurs before or at term. Although the precise role of glucocorticoids in pregnancy is not well defined, it is clear that glucocorticoids suppress inflammation in many cell types by antagonizing the acute stimulatory actions of members of the Rel/nuclear factor-B (NF-B) family on cytokine gene expression. In the present study we tested the hypothesis that during pregnancy, glucocorticoids chronically suppress inflammation in the human placenta. Cytotrophoblasts obtained from human term placentas were maintained for 48 h in culture medium supplemented with 10% charcoal-stripped calf serum with and without 100 nmol/L dexamethasone (DEX). Enzyme-linked immunosorbent assay studies revealed that cytotrophoblasts constitutively express interleukin-8 (IL-8), a known mediator of placental inflammation, between 24–96 h of culture. A 48-h treatment of cytotrophoblasts with 100 nmol/L DEX significantly reduced the production of IL-8 to 24 ± 1% of control levels (P < 0.01). DEX and cortisol mediated a dose-dependent inhibition of IL-8 expression, with ED₅₀ values of 5 and 50 nmol/L, respectively. DEX treatment also significantly reduced levels of IL-6 and tumor necrosis factor- in culture medium, suggesting that glucocorticoids coordinately reduce cytokine levels in cytotrophoblasts. As cytokine expression is regulated by NF-B and activator protein-1 (AP-1) transcription factors, electrophoretic mobility shift assays (n = 4) were used to determine whether DEX treatment altered the binding of nuclear proteins from cytotrophoblasts to labeled oligonucleotides corresponding to the B and AP-1 response elements. We observed that a 48-h treatment of cytotrophoblasts with 100 nmol/L DEX markedly reduced binding of nuclear extracts from cytotrophoblasts to the B response element. DEX treatment promoted a relatively smaller reduction of binding to the AP-1 response element. Northern blotting experiments revealed that DEX treatment did not alter the level of IB, p50, or p65 messenger ribonucleic acid, suggesting that the antiinflammatory action of glucocorticoid in cytotrophoblasts did not directly involve alterations in the level of NF-B proteins. Our results demonstrate a novel chronic suppressive action of glucocorticoid on cytokine production and nuclear binding of NF-B and AP-1 proteins in cytotrophoblasts, providing a potential mechanism through which glucocorticoids may suppress inflammation at maternal-fetal interfaces across gestation.

This article has been cited by other articles:

				E. de la Torre, M. J. Mulla, A. G. Yu, S.-J. Lee, P. B. Kavathas, and V. M. Abrahams Chlamydia trachomatis Infection Modulates Trophoblast Cytokine/Chemokine Production J. Immunol., March 15, 2009; 182(6): 3735 - 3745. [Abstract] [Full Text] [PDF]

				N. M. Scott, N. A. Hodyl, V. E. Murphy, A. Osei-Kumah, H. Wyper, D. M. Hodgson, R. Smith, and V. L. Clifton Placental Cytokine Expression Covaries with Maternal Asthma Severity and Fetal Sex J. Immunol., February 1, 2009; 182(3): 1411 - 1420. [Abstract] [Full Text] [PDF]

				R. F. Johnson, N. Rennie, V. Murphy, T. Zakar, V. Clifton, and R. Smith Expression of Glucocorticoid Receptor Messenger Ribonucleic Acid Transcripts in the Human Placenta at Term J. Clin. Endocrinol. Metab., December 1, 2008; 93(12): 4887 - 4893. [Abstract] [Full Text] [PDF]

				T. M Lindstrom and P. R Bennett The role of nuclear factor kappa B in human labour Reproduction, November 1, 2005; 130(5): 569 - 581. [Abstract] [Full Text] [PDF]

				M. Lappas, M. Permezel, H. M. Georgiou, and G. E. Rice Regulation of Phospholipase Isozymes by Nuclear Factor-{kappa}B in Human Gestational Tissues in Vitro J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2365 - 2372. [Abstract] [Full Text] [PDF]

				S. A. McCracken, E. Gallery, and J. M. Morris Pregnancy-Specific Down-Regulation of NF-{kappa}B Expression in T Cells in Humans Is Essential for the Maintenance of the Cytokine Profile Required for Pregnancy Success J. Immunol., April 1, 2004; 172(7): 4583 - 4591. [Abstract] [Full Text] [PDF]

				K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF]

				M. Lappas, M. Permezel, H. M. Georgiou, and G. E. Rice Nuclear Factor Kappa B Regulation of Proinflammatory Cytokines in Human Gestational Tissues In Vitro Biol Reprod, August 1, 2002; 67(2): 668 - 673. [Abstract] [Full Text] [PDF]

				J. A. Marrero, K. A. Matkowskyj, K. Yung, G. Hecht, and R. V. Benya Dextran sulfate sodium-induced murine colitis activates NF-kappa B and increases galanin-1 receptor expression Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G797 - G804. [Abstract] [Full Text] [PDF]